_edited.jpg)
We are a trusted sherpa for small to medium-sized pharmaceutical companies looking for late phase & patient access solutions.
We can help bring your innovative therapies faster and easier
into Europe & Sub-Saharan Africa.
Our Vision
Every patient to gain fast access to the best available medicine, and live better lives.
Our Mission
To become sherpa of choice for small to mid-sized biotech and pharmaceutical companies, by providing late phase, patient access and bespoke consulting services.
We strive to create impactful solutions, leveraging our knowledge of the cultural, operational and regulatory intricacies in European & Sub-Saharan Africa markets.
Our Ambitions
-
Strive for the best solution that meets your purpose and your budget, so we can make a meaningful impact in patient lives
​
-
​Be your partner, not your vendor, sharing your objectives, actively collaborating and working towards the outcomes you seek. Our success is rooted in your success.
​
-
To be regarded as a 'safe pair of hands', owing to our deep regulatory knowledge, understanding of cultural nuances, and pragmatic approach to execution.​​
We offer a wide range of late phase solutions, and our experienced team of associates will help meet your specific needs.
Compassionate Use/
Early Access Programs
Post-Authorisation Efficacy Studies (PAES)
Post-Authorisation Safety Studies (PASS)
Named Patient Programs
Risk Evaluation & Mitigation Strategy (REMS)
Real World Evidence Studies (RWE)
Post-Trial Access Programs
Phase IV Studies
Physician/ Patient Surveys
Registeries
Medical Chart Reviews
Medical Operations
Vendor Oversight & Management
Our Services
We can provide comprehensive bespoke support or a helping hand with our modular solutions.
Protocol Development
Site Management
Medical Services
Data Management
Regulatory Services
Biostatistics
Site Feasibility, Assessment & Selection
Patient Advocacy
